Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Also employed in agrochemical research for designing bioactive molecules with improved metabolic stability. The trifluoromethyl group contributes to lipophilicity and resistance to oxidative degradation, making it valuable in optimizing drug candidates.